Simona Ultimo
Overview
Explore the profile of Simona Ultimo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Venanzi A, Marra A, Schiavoni G, Milner S, Limongello R, Santi A, et al.
Blood Cancer Discov
. 2021 Jun;
2(3):216-225.
PMID: 34164626
Clonal hematopoiesis predisposes to hematological malignancies. However, clonal hematopoiesis is understudied in classical Hodgkin lymphoma (cHL), a mature B-cell neoplasm exhibiting the most abundant microenvironment. We analyzed clonal hematopoiesis in...
2.
Callegari E, DAbundo L, Guerriero P, Simioni C, Elamin B, Russo M, et al.
Mol Ther Nucleic Acids
. 2018 Jun;
11:485-493.
PMID: 29858083
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Prognosis is poor, and therapeutic options are limited. MicroRNAs (miRNAs) have emerged as potential therapeutic molecules against cancer....
3.
Ultimo S, Zauli G, Martelli A, Vitale M, McCubrey J, Capitani S, et al.
Oncotarget
. 2018 Apr;
9(24):17238-17254.
PMID: 29682219
Cardiovascular diseases (CVDs) are one of the most important causes of mortality worldwide, therefore the need of effective preventive strategies is imperative. Aging is associated with significant changes in both...
4.
Ultimo S, Zauli G, Martelli A, Vitale M, McCubrey J, Capitani S, et al.
Oncotarget
. 2018 Apr;
9(24):17220-17237.
PMID: 29682218
Skeletal muscle is a dynamic tissue with remarkable plasticity and its growth and regeneration are highly organized, with the activation of specific transcription factors, proliferative pathways and cytokines. The decline...
5.
Simioni C, Zauli G, Martelli A, Vitale M, Ultimo S, Milani D, et al.
Oncotarget
. 2018 Apr;
9(24):17199-17209.
PMID: 29682216
A decreased physical fitness has been reported in patients and survivors of acute lymphoblastic leukemia (ALL). This is influenced by the negative effects of the disease and by the treatments...
6.
Ferioli M, Zauli G, Martelli A, Vitale M, McCubrey J, Ultimo S, et al.
Oncotarget
. 2018 Mar;
9(17):14005-14034.
PMID: 29568412
Cancer patients experience symptoms and adverse effects of treatments that may last even after the end of treatments. Exercise is a safe, non-pharmacological and cost-effective therapy that can provide several...
7.
Ultimo S, Martelli A, Zauli G, Vitale M, Calin G, Neri L
J Cell Physiol
. 2017 Nov;
233(8):5642-5654.
PMID: 29154447
MicroRNAs (miRNAs) are a class of small noncoding RNAs which regulate the expression of target genes by binding to messenger RNAs. miRNAs play a role in various biological processes, including...
8.
Ultimo S, Simioni C, Martelli A, Zauli G, Evangelisti C, Celeghini C, et al.
Oncotarget
. 2017 Apr;
8(14):23213-23227.
PMID: 28390196
B-acute lymphoblastic leukemia (B-ALL) is a malignant disorder characterized by the abnormal proliferation of B-cell progenitors. Philadelphia chromosome-positive (Ph+) B-ALL is a subtype that expresses the Bcr-Abl fusion protein which...
9.
Simioni C, Ultimo S, Martelli A, Zauli G, Milani D, McCubrey J, et al.
Oncotarget
. 2016 Nov;
7(48):79842-79853.
PMID: 27821800
Philadelphia chromosome-positive (Ph+) Acute Lymphoblastic Leukemia (ALL) accounts for 25-30% of adult ALL and its incidence increases with age in adults >40 years old. Irrespective of age, the ABL1 fusion...
10.
Alameen A, Simioni C, Martelli A, Zauli G, Ultimo S, McCubrey J, et al.
Oncotarget
. 2016 Aug;
7(34):55690-55703.
PMID: 27494886
An attractive molecular target for novel anti-cancer therapies is the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway which is commonly deregulated in many types of cancer. Nevertheless, the effects...